Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Wore a $7 kids' shirt
Diagnosed with autism
Missouri doctor found
AI ignites controversy
Baby via surrogate
Chris Klein fired
Won’t recast Miller
Driver duct taped boy?
Reade defects to RU
Talks mental health
Return from space
4th child at 83
107M-year-old bones
Fla. fentanyl busts up
Fertility doctor fraud
Headed for contempt
Missing, found dead
Arrested over rapes
Disagrees with Dodgers
JP $26B for childcare
Manhattanhenge
Chief retires in June
Dinosaur exhibit shut
To recruit new pres
Carbon neutrality suit
2024 presidential run
False evacuation alert
Toyota data leak risk
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
1,130 results
Ars Technica26d
Moderna rakes in surprise profits ahead of 400% vaccine price hike
The company forecasts $5 billion in COVID vaccine ... our list price—when we have our updated vaccines—to be in the range of $110 to $130," Garay said. In March, Moderna CEO Stéphane Bancel ...
9don MSN
Here’s what Pfizer and Moderna say is next for their Covid vaccines
Pfizer and Moderna are ushering in a new era for their Covid shots that aims to simplify what people need to do to coexist ...
The Business Journals27d
Moderna turns focus to RSV vaccine race after Q1 profit beat
Moderna hits roadblock in flu Moderna CEO defends Covid vaccine price hike in Senate grilling Related: Moderna CEO defends Covid vaccine price hike in Senate grilling ...
Yahoo Finance3d
Moderna reports surprise profit as it books deferred COVID vaccine sales
The company did not change its forecast of $5 billion in COVID vaccine sales for the year based on advance purchase agreements. But Moderna said it was in discussions about new contracts with ...
The Motley Fool22d
Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market
The logistics involved will become more costly and complex than when Moderna was selling directly to national governments. But the company plans on increasing the price of its vaccine to as much ...
Politico Europe2d
Moderna to share vaccine tech, commits to never enforce COVID-19 jab patents
Moderna has pledged never to enforce ... to share its technology with initiatives aimed at increasing vaccine manufacturing capacity in low- and middle-income countries. “It’s a very big announcement, ...
lifesciencesipreview1d
Moderna and Pfizer face fresh suits over COVID-19 vaccine
A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech ...
Fox Business1d
moderna inc.
Moderna CEO Stéphane Bancel explains how technology from a promising new melanoma vaccine with Merck could help treat and defeat other diseases like lung, prostate and breast cancers. COVID-19 ...
Forbes26d
What’s 2022 Looking Like For Moderna Stock?
Moderna (NASDAQ ... Decline 20% In December? Vaccine specialist Novavax (NASDAQ: NVAX) - which is seen as a key player in the Covid-19 vaccine space - saw its stock price decline by about 20% ...
CNBC8d
Here’s what Pfizer and Moderna say is next for their Covid vaccines
Pfizer and Moderna say their work on their blockbuster Covid vaccines is ... length of the mRNA strand in the vaccine, according to Burton. The shot could increase the number of vaccine ...
Reuters26d
Moderna reports surprise profit as it books deferred COVID vaccine sales
A vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback